Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Archives of Internal Medicine

• Publication date

  2000-05-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.160.10.1485PMID 10826462
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention and control of influenza.

  1999cited by this paper
• Surveillance for waterborne-disease outbreaks--United States, 1995-1996.

  1998cited by this paper
• Amantadine and Rimantadine Prophylaxis of Influenza A in Nursing Homes

  1994cited by this paper
• Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections.

  1987cited by this paper
• Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics

  1983cited by this paper
• Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine

  1982cited by this paper
• A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection.

  1982cited by this paper
• SAS user's guide

  1979cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• Single-Dose Oral Influenza Antiviral Prodrug Enabled by Cholesterol Conjugation.

  2025cites this paper
• Antiviral drug development by targeting RNA binding site, oligomerization and nuclear export of influenza nucleoprotein.

  2024cites this paper
• Potential drugs in COVID-19 management.

  2023cites this paper
• Towards a qualitative understanding of the carbonyl reactivity of α-substituted ethyl 5-oxohomoadamantyl-4-carboxylates.

  2023cites this paper
• Emerging antiviral therapies and drugs for the treatment of influenza

  2022cites this paper
• Partial carbonization of quercetin boosts the antiviral activity against H1N1 influenza A virus.

  2022cites this paper
• Anti-SARS-CoV-2 Activity of Adamantanes In Vitro and in Animal Models of Infection

  2022cites this paper
• Amantadine and Fatal Events in Patients With Chronic Kidney Disease: Analysis of the Japanese Adverse Event Report Database

  2021cites this paper
• Chaiqin Qingning Capsule Inhibits Influenza Virus Infection and Inflammation In Vitro and In Vivo

  2021cites this paper
• Antivirals Against Influenza

  2021cites this paper
• Liu Shen Wan inhibits influenza a virus and excessive virus-induced inflammatory response via suppression of TLR4/NF-κB signaling pathway in vitro and in vivo.

  2020cites this paper
• San Wu Huangqin decoction regulates inflammation and immune dysfunction induced by influenza virus by regulating the NF-κB signaling pathway in H1N1-infected mice.

  2020cites this paper
• Put a cork in it: Plugging the M2 viral ion channel to sink influenza

  2020cites this paper
• Étude de la résistance des virus influenza B contemporains aux inhibiteurs de la neuraminidase et son impact sur le fitness viral

  2019cites this paper
• Antiviral Drugs and Their Toxicities Review Article

  2019cites this paper
• Apoptotic and antiproliferative effects of amantadine and rimantadine in glioblastoma cells

  2019cites this paper
• Evaluation of the non-aldehyde volatile compounds formed during deep-fat frying process.

  2018cites this paper
• A Systematic Review of NMDA Receptor Antagonists for Treatment of Neuropathic Pain in Clinical Practice

  2017cites this paper
• Antiviral Agents Against Respiratory Viruses

  2016cites this paper
• Intrathecal rimantadine induces motor, proprioceptive, and nociceptive blockades in rats.

  2016cites this paper
• Antiviral Treatments

  2016cites this paper
• A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of action

  2016cites this paper
• Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development

  2016cites this paper
• Mechanisms of resistance to neuraminidase inhibitors in influenza A viruses and evaluation of combined antiviral therapy

  2015cites this paper
• Characterizing immunogenetic factors associated with influenza cross-reactive responses and disease severity

  2014cites this paper
• Chapter 13 – Equine Influenza Infection

  2014cites this paper
• Antiviral Drugs for Influenza and Other Respiratory Virus Infections

  2014cites this paper
• Synthesis of Three Rimantadine Schiff Bases and Their Biological Effects on Serum Albumin

  2014cites this paper
• Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: influenza life-cycle and currently available drugs

  2014influential citation
• Critical Care Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury

  2013cites this paper
• Antiviral Therapy for Influenza

  2012cites this paper
• Pharmacokinetics and Safety of Coadministered Oseltamivir and Rimantadine in Healthy Volunteers: An Open‐Label, Multiple‐Dose, Randomized, Crossover Study

  2012influential citation
• Recent Advances in the Diagnosis and Treatment of Influenza Pneumonia

  2012cites this paper
• Morbidity and Mortality Weekly Report

  2012cites this paper
• The involvement of a Na⁺- and Cl⁻-dependent transporter in the brain uptake of amantadine and rimantadine.

  2012cites this paper
• Development of an anti-influenza drug screening assay targeting nucleoproteins with tryptophan fluorescence quenching.

  2012cites this paper
• Management of Influenza Virus Infections with Neuraminidase Inhibitors

  2012cites this paper
• Discovery of Novel Antiviral Agents Directed Against the Influenza A Virus Nucleoprotein

  2012cites this paper
• Prophylaxis and Treatment of Influenza Virus Infection

  2012cites this paper
• Antivirals used for influenza chemoprophylaxis.

  2012cites this paper
• Placebo-controlled trial of amantadine for severe traumatic brain injury.

  2012cites this paper
• EFFECT OF ALFERON N ON REPLICATION OF INFLUENZA A VIRUSES IN CELL CULTURES

  2012cites this paper
• Antiviral Drugs - Aspects of Clinical Use and Recent Advances

  2012cites this paper
• Évaluation de l'impact de la mutation de résistance à l'oseltamivir (H275Y) sur les capacités réplicatives et la virulence du virus pandémique A(H1N1) pdm09

  2012cites this paper
• Influenza Drug Resistance

  2011cites this paper
• rac-2-{[1-(1-Adamantyl)ethyl]iminomethyl}-5-methoxyphenol

  2011cites this paper
• Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2011cites this paper
• Crystal structure of 2-methoxy-6-{[1-(1-adamantyl)- ethyl]imino}methylphenol, C20H27NO2

  2011cites this paper
• Influenza: epidemiology, clinical features, therapy, and prevention.

  2011cites this paper
• The Pursuit of Potent Anti-influenza Activity from the Antarctic Red Marine Alga Gigartina skottsbergii

  2011cites this paper
• Influenza drug resistance.

  2011cites this paper
• Influenza: Epidemiology, Clinical Features, Therapy, and Prevention

  2011cites this paper
• Antiviral Drugs (Other than Antiretrovirals)

  2010cites this paper
• PROPOSAL FOR THE INCLUSION OF AMANTADINE AND RIMANTADINE IN THE WORLD HEALTH ORGANISATION MODEL LIST OF ESSENTIAL MEDICINES

  2009cites this paper
• Anti-influenza therapy: The emerging challenge of resistance

  2009cites this paper
• Antiviral Agents against Respiratory Viruses

  2009cites this paper
• Influenza in long-term care facilities: Preventable, detectable, treatable

  2009cites this paper
• Determination of rimantadine in rat plasma by liquid chromatography/electrospray mass spectrometry and its application in a pharmacokinetic study.

  2008cites this paper
• Influenza: Evolving Strategies in Treatment and Prevention

  2007cites this paper
• Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazoles.

  2007cites this paper
• CHAPTER 12 – Equine Influenza Infection

  2007cites this paper
• Influenza: evolving strategies in treatment and prevention.

  2007cites this paper
• Influenza: for Treatment and Prophylaxis

  2006cites this paper
• The Pandemic Threat of Avian Influenza Viruses

  2006cites this paper
• Headache: one of the most common and troublesome adverse reactions to drugs.

  2006cites this paper
• Economic Evaluation of Oseltamivir Phosphate for Postexposure Prophylaxis of Influenza in Long‐Term Care Facilities

  2005cites this paper
• Influenzapandemieplanung

  2005cites this paper
• Aphasia in a farmer after viper bite

  2005cites this paper
• Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: Report of a case series

  2005cites this paper
• Toward Preparedness: Opportunities and Obstacles

  2005cites this paper
• Visual system side effects caused by parasympathetic dysfunction after botulinum toxin type B injections

  2005cites this paper
• Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2005influential citation
• Cost-effective approaches to influenza prevention and treatment

  2005cites this paper
• Novel strategies for prevention and treatment of influenza

  2005cites this paper
• Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.

  2004cites this paper
• Antiviral therapy for influenza : a clinical and economic comparative review.

  2004cites this paper
• Adverse Effects of Amantadine and Oseltamivir Used During Respiratory Outbreaks in a Center for Developmentally Disabled Adults

  2004cites this paper
• Isolation Measures in the Hospital Management of Methicillin-Resistant Staphylococcus aureus

  2004cites this paper
• Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy

  2003cites this paper
• EFFECT OF ALFERON N ON REPLICATION OF INFLUENZA A VIRUSES IN CELL CULTURES

  2003cites this paper
• Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

  2003cites this paper
• The role of antivirals in the control of influenza.

  2003cites this paper
• Safety and Pharmacology of Oseltamivir in Clinical Use

  2003cites this paper
• Influenza Vaccination and Antiviral Therapy

  2003cites this paper
• Influenza prophylaxis in the long-term care facility: a case-control study of the risk factors for adverse drug reactions to amantadine.

  2003cites this paper
• A case for rimantadine to be marketed in Canada for prophylaxis of influenza A virus infection.

  2003cites this paper
• Influenza in the nursing home.

  2002cites this paper
• Risk factors and prophylaxis of community-acquired pneumonias

  2002cites this paper
• Antivirals for Influenza

  2002cites this paper
• Influenza Outbreaks in Long-Term-Care Facilities: How Can We Do Better?

  2002cites this paper
• Drug resistance and influenza pandemics.

  2002cites this paper
• Morbidity and Mortality Weekly Report

  2002cites this paper
• Antiviral therapy of influenza.

  2002cites this paper
• Draft WHO guidelines on the use of vaccines and antivirals during influenza pandemics.

  2002cites this paper
• Influenza in the acute hospital setting.

  2002cites this paper
• Fatores de risco e medidas profiláticas nas pneumonias adquiridas na comunidade

  2001cites this paper
• Therapeutic options for the management of influenza.

  2001cites this paper
• Separation methods for tricyclic antiviral drugs.

  2001cites this paper
• New treatments for viral respiratory tract infections—opportunities and problems

  2001cites this paper
• New Approaches for Managing Influenza in Primary Care

  2001cites this paper